RE:Biotech777
JD,
I wouldnt say it can't be a standalone drug. I think all the early discussion about better effects with one statin versus another where really more academic in trying to understand the underlying mechanism of action. Aside from that, most if not all patients who would be a candidate for 208 will be on a statin, so whether it is provided in one pill or two, I think there is still a market as a standalone. This is why I think its important for them to show it works well with more than one statin, even if it works best with Crestor. This will give it the broadest market acceptance.